SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-003003
Filing Date
2024-02-05
Accepted
2024-02-02 17:54:32
Documents
17
Period of Report
2023-11-20
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A zvra20240126_8ka.htm   iXBRL 8-K/A 34330
2 EXHIBIT 23.1 ex_621697.htm EX-23.1 3198
3 EXHIBIT 99.3 ex_621158.htm EX-99.3 392658
  Complete submission text file 0001437749-24-003003.txt   600704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zvra-20231120.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20231120_def.xml EX-101.DEF 11792
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20231120_lab.xml EX-101.LAB 15821
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20231120_pre.xml EX-101.PRE 12007
18 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240126_8ka_htm.xml XML 2983
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36913 | Film No.: 24593144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)